Champions Oncology Inc Asset Turnover Ratio (CSBR), as of fourth quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket
 


Champions Oncology Inc   (NASDAQ: CSBR)
 

Champions Oncology Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the fourth quarter 2026, Champions Oncology Inc 's asset turnover ratio sequentially decreased to 1.73 in the fourth quarter (Apr 30 2026), this is lower than usual.

Within sector only one company achieved higher asset turnover ratio in the fourth quarter 2026. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2026 compared to the preceding quarter from 216 to 263.

Asset Turnover Ratio Definition



CSBR Asset Turnover Ratio (Apr 30 2026)
IV. Quarter
(Jan 31 2026)
III. Quarter
(Oct 31 2025)
II. Quarter
(Jul 31 2025)
I. Quarter
(Apr 30 2025)
IV. Quarter
Y / Y Asset Change 38.54 % 23.77 % 19.5 % 23.81 % 23.77 %
Y / Y Revenue Change 11.99 % -2.82 % 11.46 % -0.47 % -11.76 %
Asset Turnover Ratio (TTM) 1.73 1.85 1.96 1.99 2.1
CSBR's Total Ranking # 263 # 216 # 202 # 181 # 175
Seq. Asset Change 38.54 % 7.23 % -0.62 % -6.17 % 23.77 %
Seq. Revenue Change -16.44 % 10.14 % 7.43 % 13.27 % -27.49 %



Asset Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 17
Overall Market # 263

Asset Turnover Ratio Statistics
High Average Low
2.85 1.84 0.89
(Apr 30 2019)   (Oct 31 2013)







Companies with similar Asset Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Apr 30 2026 Assets at quarter ending Apr 30 2026
The Oncology Institute Inc   3.33 $ 545.764  Millions$ 164.076  Millions
Zeo Scientifix Inc   2.90 $ 6.987  Millions$ 2.409  Millions
Lifevantage Corp  2.89 $ 193.618  Millions$ 66.906  Millions
Lifemd Inc   2.54 $ 177.869  Millions$ 70.021  Millions
Healthcare Services Group Inc   2.30 $ 1,852.277  Millions$ 803.899  Millions
Nuo Therapeutics Inc   2.28 $ 4.036  Millions$ 1.770  Millions
Vycor Medical Inc   2.15 $ 1.886  Millions$ 0.876  Millions
P3 Health Partners Inc   2.14 $ 1,472.245  Millions$ 686.487  Millions
Escalon Medical Corp   2.07 $ 11.445  Millions$ 5.522  Millions
Champions Oncology Inc   1.98 $ 59.425  Millions$ 30.010  Millions
Electrocore Inc   1.97 $ 34.458  Millions$ 17.530  Millions
Biofrontera Inc   1.93 $ 42.983  Millions$ 22.227  Millions
Aspira Women s Health inc   1.90 $ 10.792  Millions$ 5.694  Millions
Biocryst Pharmaceuticals Inc   1.88 $ 885.716  Millions$ 470.706  Millions
Integrated Biopharma Inc  1.88 $ 47.241  Millions$ 25.164  Millions
Nature s Sunshine Products inc   1.88 $ 489.104  Millions$ 260.571  Millions
Innovage Holding Corp   1.80 $ 949.172  Millions$ 527.990  Millions
Talkspace Inc   1.80 $ 239.269  Millions$ 133.225  Millions
International Stem Cell Corporation  1.79 $ 9.286  Millions$ 5.195  Millions
Iridex Corp  1.74 $ 51.160  Millions$ 29.341  Millions
Arbutus Biopharma Corp  1.74 $ 191.445  Millions$ 109.809  Millions
Progyny Inc   1.73 $ 1,292.760  Millions$ 749.237  Millions
Cv Sciences Inc   1.67 $ 11.925  Millions$ 7.157  Millions
Privia Health Group Inc   1.66 $ 2,246.592  Millions$ 1,352.700  Millions
Option Care Health Inc   1.65 $ 5,666.577  Millions$ 3,424.635  Millions
Star Equity Holdings Inc   1.62 $ 178.521  Millions$ 110.325  Millions
Chemed Corporation  1.58 $ 2,540.548  Millions$ 1,603.867  Millions
Koru Medical Systems Inc   1.58 $ 43.257  Millions$ 27.353  Millions
Adm Tronics Unlimited Inc   1.57 $ 3.347  Millions$ 2.126  Millions
Interpace Biosciences Inc   1.56 $ 35.664  Millions$ 22.905  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.